Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Description

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Conditions

Parkinson's Disease, Constipation

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Condition
Parkinson's Disease
Intervention / Treatment

-

Contacts and Locations

Old Westbury

New York Institute of Technology- Academic Health Care Center, Old Westbury, New York, United States, 11568

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Medically diagnosed with Parkinson's disease
  • * Medically diagnosed with constipation (according to Rome III criteria)
  • * Be over 40 years old
  • * No diagnosis of Parkinson's disease
  • * No diagnosis of constipation that satisfies Rome III criteria
  • * Medically diagnosed with irritable bowel syndrome
  • * Another diagnosed cause for chronic constipation
  • * Currently pregnant
  • * Have another diagnosed neurologic condition (excluding headache or migraine, headache, migraine, dysautonomia, depression or other mood disorders (unless severe or uncontrolled), dementia or cognitive changes (unless severe), diffuse lewy body dementia, REM sleep behavior disorder, normal pressure hydrocephalus, multiple system atrophy P and C types, progressive supranuclear palsy, vascular parkinsonism, corticobasal ganglionic degeneration, and drug induced parkinsonism)
  • * Spinal cord abnormality or lesion
  • * Cancer of the gastrointestinal tract, abdomen, or pelvis
  • * Anemia that has not been evaluated
  • * Unexplained weight loss, fever, night sweats, rectal bleeding, or black stools in past 2 months
  • * Active hepatitis, infectious mononucleosis, or enlarged spleen
  • * Abdominal aortic aneurysm
  • * Congenital malformation of the gastrointestinal tract
  • * Abdominal or pelvic surgery within the past 6 weeks
  • * Unable or unwilling to receive OMT.
  • * Unable or unwilling to rate one's own stools using a visual chart or to bring a picture of one's stool to each visit

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

New York Institute of Technology,

Jayme Mancini, D.O., PRINCIPAL_INVESTIGATOR, New York Institute of Technology- Academic Health Care Center

Study Record Dates

2024-12-31